These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2997921)

  • 21. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
    Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological characterization of HTLV-III infection in AIDS and related disorders.
    Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
    J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
    Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.
    Schüpbach J; Popovic M; Gilden RV; Gonda MA; Sarngadharan MG; Gallo RC
    Science; 1984 May; 224(4648):503-5. PubMed ID: 6200937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.
    Lange JM; Coutinho RA; Krone WJ; Verdonck LF; Danner SA; van der Noordaa J; Goudsmit J
    Br Med J (Clin Res Ed); 1986 Jan; 292(6515):228-30. PubMed ID: 3004634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression in Escherichia coli of open reading frame gene segments of HTLV-III.
    Chang NT; Chanda PK; Barone AD; McKinney S; Rhodes DP; Tam SH; Shearman CW; Huang J; Chang TW; Gallo RC
    Science; 1985 Apr; 228(4695):93-6. PubMed ID: 2983429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of a new human retrovirus from West African patients with AIDS.
    Clavel F; Guétard D; Brun-Vézinet F; Chamaret S; Rey MA; Santos-Ferreira MO; Laurent AG; Dauguet C; Katlama C; Rouzioux C
    Science; 1986 Jul; 233(4761):343-6. PubMed ID: 2425430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.
    Kennedy RC; Henkel RD; Pauletti D; Allan JS; Lee TH; Essex M; Dreesman GR
    Science; 1986 Mar; 231(4745):1556-9. PubMed ID: 3006246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
    Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
    Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human retroviruses: HTLV-I, II, and III and their association with leukemia and AIDS.
    Gurgo C; Gallo RC
    Ann N Y Acad Sci; 1987; 511():350-69. PubMed ID: 2894191
    [No Abstract]   [Full Text] [Related]  

  • 34. Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome.
    Barone AD; Silva JJ; Ho DD; Gallo RC; Wong-Staal FF; Chang NT
    J Immunol; 1986 Jul; 137(2):669-73. PubMed ID: 3013999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Essex M; Allan J; Kanki P; McLane MF; Malone G; Kitchen L; Lee TH
    Ann Intern Med; 1985 Nov; 103(5):700-3. PubMed ID: 2996402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.
    Arya SK; Gallo RC; Hahn BH; Shaw GM; Popovic M; Salahuddin SZ; Wong-Staal F
    Science; 1984 Aug; 225(4665):927-30. PubMed ID: 6089333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families.
    Geroldi D; Aricò M; Plebani A; Maccario R; Notarangelo LD; Duse M; Rey F; Barrè Sinoussi F; Chermann JC; Burgio GR
    Infection; 1986; 14(2):60-3. PubMed ID: 3011677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTLV-III and the etiology of AIDS.
    Gallo RC; Sarngadharan MG; Popovic M; Shaw GM; Hahn B; Wong-Staal F; Robert-Guroff M; Zaki Salahuddin S; Markham PD
    Prog Allergy; 1986; 37():1-45. PubMed ID: 3008160
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III).
    Sarngadharan MG; Bruch L; Popovic M; Gallo RC
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3481-4. PubMed ID: 2582414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients.
    Crowl R; Ganguly K; Gordon M; Conroy R; Schaber M; Kramer R; Shaw G; Wong-Staal F; Reddy EP
    Cell; 1985 Jul; 41(3):979-86. PubMed ID: 2988795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.